Halozyme Therapeutics Inc (HALO)

[maumar]

RTOR and Project Orbis can make this happen within just a few months. Check out SGEN's Tucatinib for reference.

And yet, according to Helen, it takes at least another six months for payer approval, formulary access, etc. and therefore for Halo to begin to see any significant revenues. Darzalex FasPro was approved on May 1 and Halo has not revised revenue guidance for 2020.